ClinicalTrials.Veeva

Menu

Implementation of CBT-I in Cancer Clinics

L

Laval University

Status

Enrolling

Conditions

Insomnia

Treatments

Behavioral: Web-based cognitive-behavioral therapy for insomnia (CBT-I)
Behavioral: Professionally-administered booster face-to-face CBT-I sessions

Study type

Interventional

Funder types

Other

Identifiers

NCT04817163
IC118713

Details and patient eligibility

About

Insomnia affects 30-60% of cancer patients, thus making it one of the most common disturbances in this population. When untreated, which is the rule rather than the exception, insomnia often becomes chronic. Chronic insomnia is associated with numerous negative consequences (e.g., increased risk for psychological disorders, health care costs). A large body of evidence supports the efficacy of cognitive-behavioral therapy for insomnia (CBT-I) in cancer patients, but CBT-I is still not offered routinely in cancer clinics. Self-administered CBT-I (e.g., video-based intervention) has been developed to increase patients' access to this treatment. However, results of clinical trials have suggested that these minimal treatments would be better used as a first step of a stepped care model. In stepped care, patients receive only the level of intervention they need. Generally, the entry level is a minimal, less costly, intervention (e.g., self-help intervention) followed by a more intensive form of treatment if needed (if the patient is still symptomatic). The investigators have recently assessed the efficacy of a stepped care model to administer CBT-I in cancer patients, which includes a web-based CBT-I (called Insomnet) followed by up to 3 sessions with a psychotherapist if the patient is still symptomatic. Results of this study suggest that this model of care is non-inferior to a standard face-to-face treatment (Savard, Ivers, et al., in revision), while being more cost-effective. A stepped care CBT-I could therefore be offered in routine cancer care clinics.

This project will assess the feasibility and effectiveness of implementing a stepped care CBT-I in real-world cancer clinics, using a non-randomized stepped wedge design to compare the effects of our program (active phase) with a passive phase. The program is called Insomnia in Patients with Cancer - Personalized Treatment (IMPACT). The stepped care CBT-I (active intervention) is being implemented sequentially in the four participating hospitals over a number of equally spaced time periods of 4 months (wedges), for a total of 5 time points, over a period of 20 months.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • have received a diagnosis of non-metastatic cancer (any type)
  • to be aged 18 years and older
  • to be readily able to read and understand French or English
  • having the minimum cognitive abilities to read, understand and memorize information
  • having access to Internet

Exclusion criteria

  • having a psychological comorbidity needing clinical attention (e.g., major depressive disorder)
  • having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia)
  • having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

120 participants in 1 patient group

Stepped care CBT-I
Experimental group
Treatment:
Behavioral: Professionally-administered booster face-to-face CBT-I sessions
Behavioral: Web-based cognitive-behavioral therapy for insomnia (CBT-I)

Trial contacts and locations

1

Loading...

Central trial contact

Josée Savard, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems